Janet Hemingway
Professor Janet Hemingway is Professor of Tropical Medicine at the Liverpool School of Tropical Medicine (LSTM) and founding Director of the Infection Innovation Consortium (iiCON), a leading global centre for infectious diseases R&D excellence. Responding to the growing challenge of infectious diseases, antimicrobial resistance, and emerging pandemics, iiCON brings together academic, industry, and clinical partners in a £170 million programme to transform the discovery and supply of much-needed anti-infectives and accelerate their journey to market – saving millions of lives and reducing the global burden of disease.
She is a senior technical advisor on Neglected Tropical Diseases for the Bill and Melinda Gates Foundation and has 40 years’ experience working on the biochemistry and molecular biology of specific enzyme systems associated with xenobiotic resistance. She has been PI on projects in excess of £200 million including the BMGF funded Innovative Vector Control Consortium, the ERDF funded Formulations programme and the BMGF funded Visceral Leishmaniasis Elimination programme.
Professor Hemingway was appointed the Director of LSTM in 2001 and stepped down on 1st January 2019 having overseen a period of exceptional growth of the organisation. This included the awarding of Higher Educational Institution Status & Degree Awarding powers to LSTM. She was awarded the Commander of the British Empire (CBE) for services to the Control of Tropical Disease Vectors 2012.